Explore the crucial role of HPV vaccination in public health. This preventative measure significantly reduces the risk of Human Papillomavirus infections, a...
HPV vaccination protects against infection with Human Papillomavirus (HPV), a common virus linked to several types of cancer, including cervical, anal, and certain head and neck cancers, as well as genital warts.
The HPV vaccine is typically recommended for preteen boys and girls aged 11-12, but can be administered from age 9 up to age 26 for those not previously vaccinated. Some adults aged 27-45 may also be eligible after discussing with their doctor.
Yes, extensive research and monitoring have shown the HPV vaccine to be very safe and highly effective at preventing HPV infections and the cancers they cause.
For individuals starting the vaccine series before age 15, two doses are typically given. For those starting at age 15 or older, three doses are generally recommended.